Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVER: Camostat Mesilate for COVID-19
NCT04470544Phase 2Completed
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of camostat mesilate in coronavirus disease 2019 (COVID-19). Started Jul 2020; status: completed.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04470544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470544.